Life Science REIT (LABS) Competitors

Life Science REIT (LON:LABS) and Impact Healthcare REIT (LON:IHR) are both small-cap real estate companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, institutional ownership, earnings, media sentiment, profitability, analyst recommendations, risk and valuation.

Does the media prefer LABS or IHR?

In the previous week, Life Science REIT had 1 more articles in the media than Impact Healthcare REIT. MarketBeat recorded 1 mentions for Life Science REIT and 0 mentions for Impact Healthcare REIT. Life Science REIT's average media sentiment score of 0.00 equaled Impact Healthcare REIT'saverage media sentiment score.

Company	Overall Sentiment
Life Science REIT	Neutral
Impact Healthcare REIT	Neutral

Is LABS or IHR a better dividend stock?

Life Science REIT pays an annual dividend of GBX 2 per share and has a dividend yield of 5.2%. Impact Healthcare REIT pays an annual dividend of GBX 7 per share. Life Science REIT pays out -17.7% of its earnings in the form of a dividend. Impact Healthcare REIT pays out 6,363.6% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Life Science REIT is clearly the better dividend stock, given its higher yield and lower payout ratio.

Do institutionals & insiders hold more shares of LABS or IHR?

67.3% of Life Science REIT shares are held by institutional investors. Comparatively, 59.5% of Impact Healthcare REIT shares are held by institutional investors. 7.0% of Life Science REIT shares are held by insiders. Comparatively, 9.3% of Impact Healthcare REIT shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Which has more volatility and risk, LABS or IHR?

Life Science REIT has a beta of 0.08, indicating that its share price is 92% less volatile than the S&P 500. Comparatively, Impact Healthcare REIT has a beta of 0.37, indicating that its share price is 63% less volatile than the S&P 500.

Which has stronger earnings & valuation, LABS or IHR?

Impact Healthcare REIT has higher revenue and earnings than Life Science REIT. Life Science REIT is trading at a lower price-to-earnings ratio than Impact Healthcare REIT, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Life Science REIT	£20.41M	6.68	-£40.62M	-£11.28	-3.40
Impact Healthcare REIT	£53.51M	0.00	£47.58M	£0.11	N/A

Is LABS or IHR more profitable?

Impact Healthcare REIT has a net margin of 88.90% compared to Life Science REIT's net margin of -198.99%. Impact Healthcare REIT's return on equity of 9.90% beat Life Science REIT's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Life Science REIT	-198.99%	-14.53%	1.25%
Impact Healthcare REIT	88.90%	9.90%	4.30%

Do analysts recommend LABS or IHR?

Life Science REIT currently has a consensus target price of GBX 46.50, indicating a potential upside of 21.09%. Given Life Science REIT's stronger consensus rating and higher possible upside, equities analysts plainly believe Life Science REIT is more favorable than Impact Healthcare REIT.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Life Science REIT	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.67
Impact Healthcare REIT	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Summary

Impact Healthcare REIT beats Life Science REIT on 9 of the 16 factors compared between the two stocks.